Skip to main content
Article thumbnail
Location of Repository

The CYP2D6 animal model: how to induce autoimmune hepatitis in mice

By Edith Hintermann, Janine Ehser and Urs Christen


Autoimmune hepatitis is a rare but life threatening autoimmune disease of the liver of unknown etiology1,2. In the past many attempts have been made to generate an animal model that reflects the characteristics of the human disease 3-5. However, in various models the induction of disease was rather complex and often hepatitis was only transient3-5. Therefore, we have developed a straightforward mouse model that uses the major human autoantigen in type 2 autoimmune hepatitis (AIH-2), namely hCYP2D6, as a trigger6. Type 1 liver-kidney microsomal antibodies (LKM-1) antibodies recognizing hCYP2D6 are the hallmark of AIH-27,8. Delivery of hCYP2D6 into wildtype FVB or C57BL/6 mice was by an Adenovirus construct (Ad-2D6) that ensures a direct delivery of the triggering antigen to the liver. Thus, the ensuing local inflammation generates a fertile field9 for the subsequent development of autoimmunity. A combination of intravenous and intraperitoneal injection of Ad-2D6 is the most effective route to induce a long-lasting autoimmune damage to the liver (section 1). Here we provide a detailed protocol on how autoimmune liver disease is induced in the CYP2D6 model and how the different aspects of liver damage can be assessed. First, the serum levels of markers indicating hepatocyte destruction, such as aminotransferases, as well as the titers of hCYP2D6 antibodies are determined by sampling blood retroorbitaly (section 2). Second, the hCYP2D6-specific T cell response is characterized by collecting lymphocytes from the spleen and the liver. In order to obtain pure liver lymphocytes, the livers are perfused by PBS via the portal vein (section 3), digested in collagen and purified over a Percoll gradient (section 4). The frequency of hCYP2D6-specific T cells is analyzed by stimulation with hCYP2D6 peptides and identification of IFNγ-producing cells by flow cytometry (section 5). Third, cellular infiltration and fibrosis is determined by immunohistochemistry of liver sections (section 6). Such analysis regimen has to be conducted at several times after initiation of the disease in order to prove the chronic nature of the model. The magnitude of the immune response characterized by the frequency and activity of hCYP2D6-specific T and/or B cells and the degree of the liver damage and fibrosis have to be assessed for a subsequent evaluation of possible treatments to prevent, delay or abrogate the autodestructive process of the liver

Topics: ddc:610
Year: 2012
OAI identifier:

Suggested articles


  1. (2010). Diagnosis and management of autoimmune hepatitis.
  2. (2009). New animal models for autoimmune hepatitis.
  3. (2007). Animal models for autoimmune hepatitis.
  4. (2010). Animal models of autoimmune hepatitis.
  5. (2008). Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection.
  6. (1991). LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase.
  7. (1988). Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II.
  8. (2003). Microorganisms and autoimmunity: making the barren field fertile.
  9. (2011). Retro-orbital injections in mice.
  10. (2010). Morbidity and mortality rates associated with serial bleeding from the superficial temporal vein in mice.
  11. (2011). Molecular mimicry rather than identity beaks T cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis. Manuscript Submitted,
  12. (2011). Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model.
  13. (1994). Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo.
  14. (2010). Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
  15. (1998). Failure to induce organ-specific autoimmunity by breaking of tolerance: importance of the microenvironment.
  16. (2000). Break of T cell ignorance to a viral antigen in the liver induces hepatitis.
  17. (2007). Differential priming of CD8 and CD4 T-cells in animal models of autoimmune hepatitis and cholangitis.
  18. (2004). A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens.
  19. (2002). DNA vaccination breaks tolerance for a neo-self antigen in liver: a transgenic murine model of autoimmune hepatitis.
  20. (2010). Viral triggers for autoimmunity: is the 'glass of molecular mimicry' half full or half empty?
  21. (2005). Rapid functional exhaustion and deletion of CTL following immunization with recombinant adenovirus.
  22. (2011). Adenoviral delivery of the liver autoantigen cytochrome P450 2D6 chronically activates hepatic stellate cells and induces fibrosis. Manuscript Submitted,

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.